Brought to you by 
Gene Logic acquires assets, technologies from Millennium
22 Jul 2005
Executive Summary
Gene Logic (GL, provides genomics- and bioinformatics-related drug development services) acquired from Millennium Pharmaceuticals certain assets and technologies that will enable it to set up a drug development service that identifies new therapeutic indications for already marketed drugs or failed drug candidates.
Deal Industry
- Contract Research, Toxicology Testing-CRO
- Pharmaceuticals
- Research, Analytical Equipment & Supplies
-
Biotechnology
-
Drug Discovery Tools
- ADMET
- Genomics-Proteomics
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Alliance
- Includes Equity
- Intra-Biotech Deal
- Product Purchase
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Gene Logic acquires assets, technologies from Millennium
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice